Trust Company of Toledo’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99M Sell
19,068
-23
-0.1% -$3.45K 0.25% 92
2026
Q1
$2.92M Buy
19,091
+135
+0.7% +$20.7K 0.28% 85
2025
Q4
$2.61M Hold
18,956
0.26% 89
2025
Q3
$2.43M Hold
18,956
0.24% 92
2025
Q2
$2.29M Sell
18,956
-189
-1% -$21.3K 0.25% 90
2025
Q1
$2.13M Sell
19,145
-260
-1% -$27.7K 0.28% 83
2024
Q4
$1.89M Sell
19,405
-248
-1% -$26.4K 0.25% 91
2024
Q3
$2.26M Buy
19,653
+51
+0.3% +$5.79K 0.31% 76
2024
Q2
$2.09M Hold
19,602
0.3% 74
2024
Q1
$1.9M Buy
19,602
+144
+0.7% +$14.8K 0.3% 79
2023
Q4
$1.96M Buy
19,458
+187
+1% +$18.1K 0.34% 73
2023
Q3
$1.96M Sell
19,271
-651
-3% -$66.1K 0.39% 68
2023
Q2
$2.01M Sell
19,922
-1,694
-8% -$169K 0.34% 69
2023
Q1
$1.99M Sell
21,616
-293
-1% -$25.6K 0.35% 69
2022
Q4
$1.99K Sell
21,909
-144
-0.7% -$12.1K 0.38% 66
2022
Q3
$1.68M Sell
22,053
-2,093
-9% -$173K 0.33% 71
2022
Q2
$2.04M Sell
24,146
-40
-0.2% -$3.51K 0.36% 66
2022
Q1
$2.12M Sell
24,186
-65
-0.3% -$5.63K 0.33% 72
2021
Q4
$2.12M Sell
24,251
-377
-2% -$31.3K 0.32% 76
2021
Q3
$2.01M Buy
24,628
+2,154
+10% +$194K 0.33% 78
2021
Q2
$2.05M Sell
22,474
-75
-0.3% -$6.68K 0.35% 73
2021
Q1
$1.93M Sell
22,549
-1,219
-5% -$109K 0.35% 74
2020
Q4
$2.24M Buy
23,768
+346
+1% +$30.2K 0.44% 61
2020
Q3
$2.04M Buy
23,422
+58
+0.2% +$5.03K 0.46% 58
2020
Q2
$2.04M Sell
23,364
-7
-0% -$604 0.48% 53
2020
Q1
$1.93M Sell
23,371
-3,214
-12% -$287K 0.53% 48
2019
Q4
$2.52M Buy
26,585
+396
+2% +$35.5K 0.59% 43
2019
Q3
$2.27M Buy
26,189
+731
+3% +$65.6K 0.55% 47
2019
Q2
$2.32M Sell
25,458
-2,856
-10% -$242K 0.58% 44
2019
Q1
$2.44M Sell
28,314
-89
-0.3% -$7.14K 0.62% 42
2018
Q4
$2.18M Buy
28,403
+81
+0.3% +$6.3K 0.61% 45
2018
Q3
$2.19M Sell
28,322
-1,902
-6% -$141K 0.56% 47
2018
Q2
$2.05M Buy
30,224
+34
+0.1% +$2.35K 0.55% 51
2018
Q1
$2.19M Sell
30,190
-1,936
-6% -$147K 0.58% 46
2017
Q4
$2.42M Sell
32,126
-880
-3% -$66.4K 0.6% 44
2017
Q3
$2.54M Buy
33,006
+2,187
+7% +$165K 0.65% 43
2017
Q2
$2.31M Buy
30,819
+2,006
+7% +$142K 0.6% 44
2017
Q1
$1.92M Sell
28,813
-437
-1% -$29.1K 0.52% 55
2016
Q4
$1.91M Sell
29,250
-101
-0.3% -$6.55K 0.53% 48
2016
Q3
$2.08M Buy
29,351
+963
+3% +$70.2K 0.59% 45
2016
Q2
$2.1M Buy
28,388
+929
+3% +$64.2K 0.6% 45
2016
Q1
$1.78M Sell
27,459
-335
-1% -$22.8K 0.54% 46
2015
Q4
$2.14M Buy
27,794
+107
+0.4% +$8.5K 0.66% 44
2015
Q3
$2.28M Sell
27,687
-296
-1% -$26.3K 0.72% 41
2015
Q2
$2.47M Sell
27,983
-20
-0.1% -$1.83K 0.72% 38
2015
Q1
$2.47M Buy
28,003
+613
+2% +$54.4K 0.74% 38
2014
Q4
$2.27M Buy
27,390
+854
+3% +$70.8K 0.69% 39
2014
Q3
$2.24M Sell
26,536
-2,169
-8% -$175K 0.74% 35
2014
Q2
$2.33M Buy
28,705
+423
+1% +$33.3K 0.69% 39
2014
Q1
$2.15M Buy
28,282
+4,364
+18% +$318K 0.65% 40
2013
Q4
$1.72M Buy
23,918
+1,241
+5% +$86.3K 0.56% 47
2013
Q3
$1.56M Sell
22,677
-3,815
-14% -$252K 0.56% 43
2013
Q2
$1.68M Buy
+26,492
New +$1.72M 0.62% 36

Other funds holding NVS

Trust Company of Toledo's NVS Position: Q2 2026 in Review

Trust Company of Toledo reduced its Novartis (NVS) stake by 0.12% in Q2 2026, selling an estimated $3.45K and leaving 19,068 shares worth $2.99M. The position accounts for 0.25% of the portfolio, ranked #92.

Trust Company of Toledo first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. 911 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Trust Company of Toledo held 19,068 shares of Novartis worth $2.99M as of Q2 2026.
  • Trust Company of Toledo sold 23 Novartis shares in Q2 2026, an estimated $3.45K.
  • Novartis made up 0.25% of Trust Company of Toledo's portfolio in Q2 2026, its #92 holding.
  • Trust Company of Toledo first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • 911 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.